瑞普生物(300119.SZ):獲得三項發明專利證書
格隆匯4月9日丨瑞普生物(300119.SZ)公佈,公司全資子公司瑞普(保定)生物藥業有限公司獲得由國家知識產權局頒發的三項發明專利證書,分別為:禽腺病毒毒株、滅活疫苗及製備方法;一種豬肺炎支原體疫苗效力測定方法;一種雞毒支原體疫苗效力測定方法。
“禽腺病毒毒株、滅活疫苗及製備方法”針對2014年以來國內廣泛流行的新發疫病禽腺病毒病,研究了應用瑞普生物研究院自行分離的疫苗毒株製備禽腺病毒滅活疫苗的技術方法,為公司獸用疫苗新產品的開發奠定了基礎。
“一種豬肺炎支原體疫苗效力測定方法”和“一種雞毒支原體疫苗效力測定方法”,兩項專利技術建立的新型的血清學檢驗方法替代了傳統的免疫攻毒保護法,對支原體疫苗的免疫效果進行評價,操作更簡單,重複性更強,縮短檢測週期,提高檢測效率。
以上專利的獲得不會對公司近期生產經營產生重大影響,體現了公司的研發和創新能力,有利於進一步完善公司的知識產權保護體系,充分發揮自主知識產權優勢,促進技術創新、產品創新,提升公司核心競爭力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.